小鵬汽車(09868.HK)加速歐洲市場佈局 奧地利工廠今季啟動生產
內媒報道,小鵬汽車-W(09868.HK)(XPEV.US)正式宣布歐洲本地化生產的重要規劃,與位於奧地利格拉茨的麥格納工廠展開深度合作,借助該工廠現有的成熟生產線,大力推動電動汽車在歐洲的本地化生產進程。
小鵬汽車表示,首個歐洲本地化生產項目於今年第三季度在奧地利格拉茨麥格納工廠正式啟動,首批小鵬G6與小鵬G9順利量產下線。該工廠未來將投產更多小鵬車型。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.